Altimmune Inc (ALT)
4.77
+0.02
(+0.53%)
USD |
NASDAQ |
Apr 02, 14:27
Altimmune Shareholders Equity (Quarterly): 123.51M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viking Therapeutics Inc | 880.28M |
| Eli Lilly and Co | 14.19B |
| Amgen Inc | 5.877B |
| Terns Pharmaceuticals Inc | 345.87M |
| Pfizer Inc | 88.20B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 139.31M |
| Total Liabilities (Quarterly) | 15.80M |
| Current Ratio | 13.11 |